OncoLog, Volume 59, Number 02, February 2014

Authors

Sarah Bronson, The University of Texas MD Anderson Cancer Center
Kathryn L. Hale, The University of Texas MD Anderson Cancer Center
Bryan Tutt, The University of Texas MD Anderson Cancer Center
M. Yeoman, The University of Texas MD Anderson Cancer Center

Files

Contents

• New Approaches Revolutionize the Treatment of Advanced Melanoma: Recent breakthroughs in immunotherapy and targeted therapy have improved outcomes for patients with advanced melanoma
• Comprehensive Tobacco Treatment Approach Helps Patients Quit on Their Terms: Kicking a tobacco habit is a formidable task. Quitting tobacco after a diagnosis of cancer, can be even more difficult
• Targeted Drug Shows Promise Against Advanced Breast Cancer: Adding the experimental kinase inhibitor palbociclib to standard hormonal therapy may delay disease progression in patients with advanced breast cancer that is estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (HER@) negative
• HOUSE CALL: Avoiding Food-Drug Interactions: Some foods and medicines don’t mix
• INBRIEF: PKM2 Identified as Potential Prognostic Marker for Glioblastoma

Publication Date

2-1-2014

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Disciplines

History of Science, Technology, and Medicine | Oncology

Recommended Citation

Bronson, Sarah; Hale, Kathryn L.; Tutt, Bryan; and Yeoman, M., "OncoLog, Volume 59, Number 02, February 2014" (2014). OncoLog MD Anderson's Report to Physicians (All issues). 244.
https://openworks.mdanderson.org/oncolog/244

Conditions Governing Access

Open